E72.12
Methylenetetrahydrofolate reductase deficiency
Clinical Classification Guidelines
Medical Intelligence & Overview
Methylenetetrahydrofolate reductase deficiency, classified under ICD-10 code E72.12, is a rare inherited disorder that affects how the body processes folate and homocysteine. This enzyme deficiency stems from genetic mutations and can influence various bodily functions, especially those related to the cardiovascular system and neurological health. While some individuals with the deficiency remain asymptomatic, others may experience a range of health issues due to elevated homocysteine levels or impaired folate metabolism. Understanding this condition helps in identifying potential health risks associated with MTHFR deficiency and guides appropriate management strategies.
Causes & Symptoms
Clinical Causes: Genetic mutations in the MTHFR gene, most commonly C677T or A1298C variants Inheritance in an autosomal recessive pattern, meaning an individual must inherit mutated copies of the gene from both parents Potential environmental factors that may exacerbate the condition, such as poor diet or exposure to certain toxins
Key Symptoms: Elevated homocysteine levels in the blood (hyperhomocysteinemia) Increased risk of blood clots or thrombosis Neurological symptoms such as migraines, depression, or cognitive difficulties Pregnancy-related complications like recurrent miscarriages or preeclampsia Possible developmental delays in children with severe deficiencies
Diagnostic & Treatment
Diagnosis Path: Diagnosis of MTHFR deficiency involves a combination of blood tests to measure homocysteine and folate levels, along with genetic testing to identify mutations in the MTHFR gene. Healthcare providers may also assess clinical history, especially if there are recurrent pregnancy losses or signs of clot formation. It is important for testing to be interpreted alongside other metabolic assessments to accurately determine the presence and impact of the enzyme deficiency.
Treatment Protocols: Supplementation with folic acid, methylfolate, or other B vitamins such as B6 and B12 Dietary modifications to incorporate folate-rich foods like leafy greens, legumes, and fortified grains Regular monitoring of homocysteine levels to evaluate response to treatment Addressing any underlying health conditions that may contribute to blood clot risks Lifestyle changes such as avoiding smoking and managing cardiovascular risk factors
Clinical Advice & FAQs
Billing Guidance
Is E72.12 a billable ICD-10 code?
Yes, E72.12 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E72.12?
Clinical documentation must specify the nature of Methylenetetrahydrofolate reductase deficiency and any associated comorbidities for accurate reporting.
Cite this Clinical Reference